Svane IM - Search Results

1

Safety, immune and clinical responses in metastatic melanoma patients vaccinated with a long peptide derived from indoleamine 2,3-dioxygenase in combination with ipilimumab.

Bjoern J, Iversen TZ, Nitschke NJ, Andersen MH, Svane IM. Bjoern J, et al. Among authors: svane im. Cytotherapy. 2016 Aug;18(8):1043-1055. doi: 10.1016/j.jcyt.2016.05.010. Cytotherapy. 2016. PMID: 27378345 Clinical Trial.

2

HLA-B35-restricted immune responses against survivin in cancer patients.

Reker S, Becker JC, Svane IM, Ralfkiaer E, Straten PT, Andersen MH. Reker S, et al. Among authors: svane im. Int J Cancer. 2004 Mar 1;108(6):937-41. doi: 10.1002/ijc.11634. Int J Cancer. 2004. PMID: 14712500 Free article.

3

Identification of novel survivin-derived CTL epitopes.

Reker S, Meier A, Holten-Andersen L, Svane IM, Becker JC, thor Straten P, Andersen MH. Reker S, et al. Among authors: svane im. Cancer Biol Ther. 2004 Feb;3(2):173-9. doi: 10.4161/cbt.3.2.611. Epub 2004 Feb 1. Cancer Biol Ther. 2004. PMID: 14726703

4

Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study.

Svane IM, Pedersen AE, Johnsen HE, Nielsen D, Kamby C, Gaarsdal E, Nikolajsen K, Buus S, Claesson MH. Svane IM, et al. Cancer Immunol Immunother. 2004 Jul;53(7):633-41. doi: 10.1007/s00262-003-0493-5. Epub 2004 Feb 25. Cancer Immunol Immunother. 2004. PMID: 14985857 Free PMC article. Clinical Trial.

5

Impaired circulating myeloid DCs from myeloma patients.

Do TH, Johnsen HE, Kjaersgaard E, Taaning E, Svane IM. Do TH, et al. Among authors: svane im. Cytotherapy. 2004;6(3):196-203. doi: 10.1080/14653240410006004. Cytotherapy. 2004. PMID: 15203976

6

Immunogenicity of Bcl-2 in patients with cancer.

Andersen MH, Svane IM, Kvistborg P, Nielsen OJ, Balslev E, Reker S, Becker JC, Straten PT. Andersen MH, et al. Among authors: svane im. Blood. 2005 Jan 15;105(2):728-34. doi: 10.1182/blood-2004-07-2548. Epub 2004 Sep 14. Blood. 2005. PMID: 15367432 Free article.

7

Spontaneous T-cell responses against peptides derived from the Taxol resistance-associated gene-3 (TRAG-3) protein in cancer patients.

Meier A, Reker S, Svane IM, Holten-Andersen L, Becker JC, Søndergaard I, Andersen MH, Thor Straten P. Meier A, et al. Among authors: svane im. Cancer Immunol Immunother. 2005 Mar;54(3):219-28. doi: 10.1007/s00262-004-0578-9. Epub 2004 Oct 2. Cancer Immunol Immunother. 2005. PMID: 15580499 Free PMC article.

8

[Dendrite cell-based cancer vaccines--clinical application].

Svane IM, Berntsen A, Trepiakas R, Pedersen AE. Svane IM, et al. Ugeskr Laeger. 2006 Apr 3;168(14):1415-20. Ugeskr Laeger. 2006. PMID: 16584668 Review. Danish.

9

Efficient tumor cell lysis mediated by a Bcl-X(L) specific T cell clone isolated from a breast cancer patient.

Sørensen RB, Hadrup SR, Køllgaard T, Svane IM, thor Straten P, Andersen MH. Sørensen RB, et al. Among authors: svane im. Cancer Immunol Immunother. 2007 Apr;56(4):527-33. doi: 10.1007/s00262-006-0200-4. Epub 2006 Jul 19. Cancer Immunol Immunother. 2007. PMID: 16850344 Free PMC article.

10

The universal character of the tumor-associated antigen survivin.

Andersen MH, Svane IM, Becker JC, Straten PT. Andersen MH, et al. Among authors: svane im. Clin Cancer Res. 2007 Oct 15;13(20):5991-4. doi: 10.1158/1078-0432.CCR-07-0686. Clin Cancer Res. 2007. PMID: 17947459 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

317 results

Search Page